Maternal and neonatal tetanus
- PMID: 17854885
- DOI: 10.1016/S0140-6736(07)61261-6
Maternal and neonatal tetanus
Erratum in
- Lancet. 2007 Dec 8;370(9603):1906
Abstract
Maternal and neonatal tetanus are important causes of maternal and neonatal mortality, claiming about 180 000 lives worldwide every year, almost exclusively in developing countries. Although easily prevented by maternal immunisation with tetanus toxoid vaccine, and aseptic obstetric and postnatal umbilical-cord care practices, maternal and neonatal tetanus persist as public-health problems in 48 countries, mainly in Asia and Africa. Survival of tetanus patients has improved substantially for those treated in hospitals with modern intensive-care facilities; however, such facilities are often unavailable where the tetanus burden is highest. The Maternal and Neonatal Tetanus Elimination Initiative assists countries in which maternal and neonatal tetanus has not been eliminated to provide immunisation with tetanus toxoid to women of childbearing age. The ultimate goal of this initiative is the worldwide elimination of maternal and neonatal tetanus. Since tetanus spores cannot be removed from the environment, sustaining elimination will require improvements to presently inadequate immunisation and health-service infrastructures, and universal access to those services. The renewed worldwide commitment to the reduction of maternal and child mortality, if translated into effective action, could help to provide the systemic changes needed for long-term elimination of maternal and neonatal tetanus.
Comment in
-
Neonatal tetanus.Lancet. 2008 Feb 2;371(9610):385-6. doi: 10.1016/S0140-6736(08)60198-1. Lancet. 2008. PMID: 18242410 No abstract available.
Similar articles
-
Progress towards the global elimination of neonatal tetanus.World Health Stat Q. 1992;45(2-3):248-56. World Health Stat Q. 1992. PMID: 1462659
-
Neonatal tetanus in the world today.Bull World Health Organ. 1984;62(4):647-69. Bull World Health Organ. 1984. PMID: 6386211 Free PMC article. Review.
-
Neonatal tetanus elimination in Pakistan: progress and challenges.Int J Infect Dis. 2012 Dec;16(12):e833-42. doi: 10.1016/j.ijid.2012.07.015. Epub 2012 Aug 30. Int J Infect Dis. 2012. PMID: 22940280 Review.
-
Determinants of maternal immunization in developing countries.Vaccine. 2015 Jun 12;33(26):2971-7. doi: 10.1016/j.vaccine.2015.04.070. Epub 2015 Apr 30. Vaccine. 2015. PMID: 25936666
-
Use of tetanus toxoid for the prevention of neonatal tetanus. 1. Reduction of neonatal mortality by immunization of non-pregnant and pregnant women in rural Bangladesh.Bull World Health Organ. 1982;60(2):261-7. Bull World Health Organ. 1982. PMID: 6980736 Free PMC article.
Cited by
-
Maternal and Neonatal Tetanus Elimination: Where are We Now?Res Rep Trop Med. 2021 Nov 23;12:247-261. doi: 10.2147/RRTM.S201989. eCollection 2021. Res Rep Trop Med. 2021. PMID: 34849046 Free PMC article. Review.
-
Knowledge, attitudes and practices related to tetanus toxoid vaccination in women of childbearing age: A cross-sectional study in peri-urban settlements of Karachi, Pakistan.J Infect Prev. 2017 Sep;18(5):232-241. doi: 10.1177/1757177416689722. Epub 2017 Feb 1. J Infect Prev. 2017. PMID: 29317900 Free PMC article.
-
Specific antibodies against vaccine-preventable infections: a mother-infant cohort study.BMJ Open. 2013 Apr 11;3(4):e002473. doi: 10.1136/bmjopen-2012-002473. Print 2013. BMJ Open. 2013. PMID: 23585389 Free PMC article.
-
Comparison of Wealth-Related Inequality in Tetanus Vaccination Coverage before and during Pregnancy: A Cross-Sectional Analysis of 72 Low- and Middle-Income Countries.Vaccines (Basel). 2024 Apr 17;12(4):431. doi: 10.3390/vaccines12040431. Vaccines (Basel). 2024. PMID: 38675813 Free PMC article.
-
Tetanus in Ethiopia: unveiling the blight of an entirely vaccine-preventable disease.Curr Neurol Neurosci Rep. 2012 Dec;12(6):655-65. doi: 10.1007/s11910-012-0314-3. Curr Neurol Neurosci Rep. 2012. PMID: 22996275 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical